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Variant detection sensitivity and biases in
whole genome and exome sequencing
Alison M Meynert*, Morad Ansari, David R FitzPatrick and Martin S Taylor
Abstract
Background: Less than two percent of the human genome is protein coding, yet that small fraction harbours the
majority of known disease causing mutations. Despite rapidly falling whole genome sequencing (WGS) costs, much
research and increasingly the clinical use of sequence data is likely to remain focused on the protein coding exome.
We set out to quantify and understand how WGS compares with the targeted capture and sequencing of the exome
(exome-seq), for the specific purpose of identifying single nucleotide polymorphisms (SNPs) in exome targeted
regions.
Results: We have compared polymorphism detection sensitivity and systematic biases using a set of tissue samples
that have been subject to both deep exome and whole genome sequencing. The scoring of detection sensitivity was
based on sequence down sampling and reference to a set of gold-standard SNP calls for each sample. Despite
evidence of incremental improvements in exome capture technology over time, whole genome sequencing has
greater uniformity of sequence read coverage and reduced biases in the detection of non-reference alleles than
exome-seq. Exome-seq achieves 95% SNP detection sensitivity at a mean on-target depth of 40 reads, whereas WGS
only requires a mean of 14 reads. Known disease causing mutations are not biased towards easy or hard to sequence
areas of the genome for either exome-seq or WGS.
Conclusions: From an economic perspective, WGS is at parity with exome-seq for variant detection in the targeted
coding regions. WGS offers benefits in uniformity of read coverage and more balanced allele ratio calls, both of which
can in most cases be offset by deeper exome-seq, with the caveat that some exome-seq targets will never achieve
sufficient mapped read depth for variant detection due to technical difficulties or probe failures. As WGS is intrinsically
richer data that can provide insight into polymorphisms outside coding regions and reveal genomic rearrangements,
it is likely to progressively replace exome-seq for many applications.
Keywords: SNP, Sensitivity, Protein-coding genes, Next-generation sequencing, Whole genome sequencing, Exome
sequencing
Background
The cost of sequencing DNA has decreased steeply since
the introduction of next-generation short read technolo-
gies [1]. It is now at the point where cohorts of whole
human genomes are sequenced for study. However, inves-
tigations of disease-causing variation continue to focus
on the protein-coding exome, which is a small fraction
of the whole genome. It contains fewer repetitive ele-
ments than non-coding regions and contains most of the
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causal disease variants identified to date [2]. Addition-
ally, experimental approaches to determine the function
of candidate disease variants at protein coding or tran-
script splice sites are well developed and accepted by the
research community.
For these reasons, exome centric analysis will remain
common in research and is increasingly used in clini-
cal genetic settings [3]. The targeted capture followed by
sequencing of specific regions, such as the 30 Mb human
exome (exome-seq), has proven to be a cost-effective
and productive strategy for the identification of single
nucleotide polymorphisms (SNPs) and small insertions
and deletions in this rich vein of the genome. However,
© 2014 Meynert et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated.
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as sequencing technology rapidly improves and cost per
sequenced nucleotide falls, there is likely to come a point
where it is more economic to sequence a whole genome
rather than target-capture and sequence, even if analysis is
confined to just the exome. Where that point lies depends
both on the costs of the technologies but also on the uni-
formity of coverage and biases inherent in the data. In
this work we set out to compare exome-seq with whole
genome sequencing (WGS) in terms of their sensitivity to
correctly detect known variants over the whole exome.
The process of exome-seq has known issues that impact
negatively on SNP detection sensitivity. These include
PCR amplification, which tends towards lower cover-
age in GC-rich regions due to annealing during ampli-
fication [4-6], and the preferential capture of reference
sequence alleles, which biases the allele distribution away
from alternate alleles at heterozygous SNP sites [7-9].
Exome-seq produces a relatively heterogeneous profile of
read coverage over target regions when compared to the
more homogeneous WGS [10]. Better uniformity of cov-
erage yields improved SNP detection sensitivity across the
regions of interest [9-11].
Previous estimates of the amount of sequencing
required to accurately identify SNPs in WGS and exome-
seq are variable. Bentley et al. estimated that 15X
mapped read depth of WGS samples would be suffi-
cient to detect almost all homozygous SNPs and 33X
for almost all heterozygous SNPs [12]. 50X was esti-
mated by Ajay et al. for all SNPs and small indels
[13]. Depending on the capture kit, Clark et al. cal-
culated that exome-seq required 80X mean on-target
depth to reach the common threshold of 10X per-site
depth in 90% or more of all targeted regions [10].
Our previous work on some of the original exome-seq
target capture kits estimated between 20X and 46X mean
on-target depth was required to successfully genotype
95% of heterozygous SNPs, with the commercially avail-
able kits at the higher end of that range.
We examine previously established measures of SNP
detection sensitivity [9] in coding regions from exome-
seq and WGS samples. SNP detection sensitivity can be
measured both at a site level, considering the number
of reads mapped over a given position in the reference
genome, or as an overall estimate based on the mapped
read depth across a region or regions (Figure 1). We com-
puted the per-site measure for different sequencing tech-
nologies and compared them directly when the per-site
mapped depth is identical (point A, Figure 1). Because of
the allele distribution bias in exome-seq, we expected that
WGS would require fewer reads to successfully genotype
heterozygous SNPs. The greater variability in coverage
from exome-seq means that greater mean on-target depth
should be required to identify the same proportion of
SNPs in exome-seq as compared to WGS [10] (points B
and C, Figure 1). We measured the estimated overall SNP
detection sensitivity across a given set of target regions
by using the per-site SNP detection sensitivity for the
sequencing method combined with the coverage distri-
bution for samples sequenced by the same method. This
relates the overall sensitivity of a method to the mean on-
target depth in the sample, which can be used to calculate
the cost of sequencing to a given sensitivity.
Results and discussion
Site level SNP detection sensitivity
Site level SNP detection sensitivity is the mapped
read depth directly over a polymorphic site that
is required to reliably call that polymorphism [9].
Figure 1 SNP detection sensitivity in exome and whole genome sequencing. Exome and whole genome sequencing mapped read depth
across the exons of an example gene. The grey vertical lines denote exon boundaries. At point A, the depth is equal and we can compare the
per-site SNP detection sensitivity. Points B and C are examples of unequal depth, where per-site sensitivity cannot be directly compared, but the
overall estimated sensitivity of the region can be calculated to account for the variability in coverage.
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Ten human whole genome sequences (TCGA-WGS)
and matched whole exome sequences from the same
patients, plus ten additional exome samples (all TCGA-
WXS), were obtained from The Cancer Genome Atlas
(TCGA; only non-tumour samples were used). A fur-
ther six human whole genome samples (1KG-WGS)
were obtained from the 1000 Genomes Project [14],
all aligned to the reference genome. An additional 13
exome samples were captured, sequenced, and aligned
in house as part of two ongoing disease studies (HGU-
WXS) (Methods, Additional file 1: Table S1, Additional
file 2: Tables S2–S4, Additional file 1: Figures S1 and S2).
We randomly downsampled all 49 alignments to simu-
late shallower sequencing and called SNPs in the coding
regions of the alignments as in our previous work [9].
We defined a gold-standard set of SNP calls for each
sample, based on the full alignments (using all avail-
able reads for the sample, i.e. not down sampled) and
confined to known HapMap 3.3 variants (Additional
file 2: Table S5, Additional file 1: Figure S3, Additional
file 3). We validated the use of HapMap 3.3 variants
as the gold standard in sample NA12878 by compar-
ing results to those obtained using the Genome in a
Bottle 2.18 highly confident variant call set [15] as the
gold standard (Additional file 1: Figure S4). We measured
sensitivity as a function of the per-site depth for heterozy-
gous (Figure 2) and homozygous (not shown) SNPs. We
focused on heterozygous SNPs as the more challenging
problem: only 2-3X per-site depth was required to accu-
rately detect at least 95% of homozygous SNPs in all four
data sets.
The oldest data set (1KG-WGS) had the worst per-
formance for heterozygous SNPs, requiring at least 13X
to reach 95% sensitivity. This could be due to shorter
read lengths or higher sequencing error rates on older
technologies. The difference in per-site SNP detection
sensitivity between this data set and the newer three data
sets indicates that analysis of older data sets requires more
stringent thresholds.
All of the newer three data sets, which are contempo-
rary with each other, performed similarly. The TCGA-
WXS samples reached 95% sensitivity at 10X, while the
HGU-WXS and TCGA-WGS samples had a slight edge
at 9X. There was a slight advantage in sensitivity for the
newer TCGA-WGS data set as opposed to the two exome-
seq data sets, though this equalized at 12-13X per-site
depth. Given that read lengths are the same between these
three data sets and most samples were sequenced on the
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Figure 2 Site level heterozygous SNP detection sensitivity for exome and whole genome sequencing samples. Sensitivity is calculated from
heterozygous HapMap 3.3 positions [16] located within coding sequence as determined by Ensembl 72 [17]. 95% sensitivity is reached at per-site
mapped depths of 9X for the TCGA-WGS samples, 10X for the TCGA-WXS and HGU-WXS samples, and 13X for the 1KG-WGS samples.
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same generation of machine, this difference was likely
caused by reference bias from the capture step. Low-depth
exome sequencing projects may need to take this into
consideration.
All the data sets converged at 99% sensitivity for sites
with between 15 and 20X mapped depth. The recall
curves were virtually identical for variants drawn from
the Ensembl 72 coding regions and each of the sets
of targeted regions from the two exome sequencing
data sets (Additional file 1: Figure S5, Additional file 1:
Table S6). Specificity (1 - false positive rate) reached 99%
at 9X for the 1KG-WGS data set and 8X for the other three
(Additional file 1: Figure S6).
Direct comparison ofmatched samples
The matched WGS and exome-seq samples from TCGA
were compared directly. Considering only SNPs in the
regions targeted by the exome capture kit, 98.3 ± 0.007%
of variant sites were called as polymorphic by both meth-
ods with matched genotypes, and 0.3 ± 0.3% with mis-
matched genotypes. A further 1.3 ± 0.4% were called
as polymorphic by whole genome sequencing only, and
0.1 ± 0.1% by exome sequencing only. 93% of the sites
called as polymorphic only by whole genome sequencing
had greater mapped per-site depth in the WGS sam-
ple than in the exome-seq sample (Additional file 1:
Figure S7). Of these, 34% are at sites with no reads in the
exome-seq sample, which could be due to probe failure or
other technical problems.
The majority of mismatched genotypes were cases
where the whole genome sample was genotyped as het-
erozygous and the exome sample was genotyped as
homozygous (Additional file 1: Figure 8a and Table S7).
Mismatches generally occurred at sites where the whole
genome sample had higher per-site mapped depth than
the exome sample (Additional file 1: Figure S8b). Some
sites with very high mapped depth in the exome sample
also had mismatched genotypes with the whole genome
sample. This could be caused by random accumulation
of the same sequencing error at a given position if that
position is sequenced to very high mapped depth. Both of
these results imply that improving uniformity of coverage
will improve SNP detection sensitivity.
We took the subset of coding SNPs where the alle-
les and genotypes were identical in the full alignments
between the TCGA-WGS and TCGA-WXS samples for
the same individual, and compared the mapped depth of
sequencing required to correctly identify the genotypes
of both heterozygous and homozygous SNPs (Figure 3).
To accurately genotype 95% of heterozygous SNPs, the
TCGA-WGS data set required a minimum per-site depth
of 12X and the TCGA-WXS data set required 34X. For
homozygous sites, the minimum per-site depths were 8X
and 33X respectively.
Effect of grouped and single sample variant calling
The results in this paper are derived from calling variants
for one sample at a time; however, it is standard prac-
tice to call variants in groups of samples (pooled calling)
as this improves accuracy by allowing the use of reads
across all samples at a position to determine the presence
of a polymorphism. To investigate the relative benefits of
pooled calling, we grouped our samples by data source,
called variants on the full alignments for each group,
and compared the results to the variants called on the
full alignments by single sample calling (Additional file 2:
Table S8a).
For sites in HapMap 3.3, there were very few cases of
mismatched genotypes between the two calling methods;
the main difference was in additional sites called as poly-
morphic when the samples were grouped. For all data sets,
of the sites with mismatched genotypes or where only
one method called the site as polymorphic, the mapped
read depth was on average lower than for sites where
genotypes were matched (Additional file 1: Figure S9).
The two exome capture data sets benefited significantly
from grouped sample calling, with a mean of 186 (594)
heterozygous and 100 (326) homozygous additional sites
genotyped for the HGU-WXS (TCGA-WXS) data set.
These data sets had the most samples, which may have
been the major cause of the improvement, or possibly
the uneven coverage of the exomes was smoothed by the
inclusion of multiple samples. The 1KG-WGS data set
also benefited to the same degree as the exome capture
data sets for heterozygous sites (mean 317 additional),
but not for homozygous sites (mean 52 additional), per-
haps because the 1KG-WGS data set comprises two family
trios, which would help to resolve heterozygous positions.
The number of variants called from the TCGA-WGS
data set did not improve greatly with grouped sample
calling (mean of 37 heterozygous and 11 homozygous
additional sites), though there were a large number of
mismatched genotypes between the group calling and
the single-sample calling. This was observed in only 6 of
the samples; the other 4 all had ≤ 2 mismatched geno-
types. The TCGA-WGS samples had both excellent mean
on-target depth and uniformity of coverage, which made
them easy to accurately genotype using single-sample
variant calling. Grouped variant calling would therefore
not provide the same boost as with the other data sets.
We also examined rare variants, as defined by absence
from HapMap 3.3, presence in the Exome Variant Server
ESP6500 (http://evs.gs.washington.edu/EVS) set at less
than 0.01 minor allele frequency, and minimum geno-
type quality at least 60 in each of the grouped and single
sample call sets (Additional file 2: Table S8b). The 1KG-
WGS, HGU-WXS, TCGA-WGS, and TCGA-WXS data
sets gained a mean of an additional 0.28%, 0.25%, 1.23%,
and 4.30% respectively of these rare variants by grouped
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Figure 3Minimum per-site mapped depth required to correctly genotype a site in matched TCGA exome and genome samples. Coding
SNPs at HapMap 3.3 positions [16] with identical genotypes and alleles between matched TCGA exome and genome samples in the full alignments.
a) The minimum per-site mapped depth required for a correct genotype call in TCGA-WXS and TCGA-WGS matchd samples. b) The number of extra
reads required to correctly identify a SNP in the TCGA-WXS sample.
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calling, while losing only 0.31%, 0.04%, 0.19%, and 0.35%
that were only called in the single sample method. The
TCGA-WXS data set gained by far the most rare variants
by use of the grouped calling, similar to the results for
known common HapMap 3.3 sites.
Overall estimated sensitivity
Using the depth of coverage distributions for every down-
sampled and full alignment on the regions targeted by
each of the two exome capture kits, and the per-site SNP
detection sensitivity for each data set, we calculated the
overall estimated sensitivity for each of the four data sets.
We compared this measure to the mean on-target read
depth across the targeted regions and found that the two
whole genome data sets performed considerably better
than each of the exome data sets (Figure 4). In order to
reach an overall estimated 95% sensitivity for heterozy-
gous SNPs in the targeted regions, the 1KG-WGS samples
required at least 18X and the TCGA-WGS 14X mean on-
target depth. The HGU-WXS samples required 41Xmean
on-target depth, and the TCGA-WXS samples 39X. This
effect is almost entirely due to the lack of uniformity in
coverage for the exome samples: The difference in per-site
sensitivity is relatively slight between the two exome data
sets and the TCGA-WGS data set (Figure 2), and both of
them perform better than the 1KG-WGS data set on that
measure.
Our estimates for WGS required mapped depth are
lower than those from Bentley et al. (33X) [12] and Ajay
et al. (50X) [13], though both were attempting to quan-
tify detection of all or almost all SNPs rather than to a
given percentage as here. It is unsurprising that the harder
to sequence variants will require proportionally greater
additional numbers of reads to accurately genotype. Addi-
tionally, we are analysing only coding sequence variants,
which are in the least repetitive portion of the human
genome. The higher figures reported by the other WGS
analyses will be influenced by the different qualities of
non-coding sequence, especially repetitive regions. The
TCGA-WXS and HGU-WXS exome-seq data sets used
in this analysis can update the figures provided by Clark
et al. of 80X mean on-target depth required for 10X
mapped read depth in 90% of targeted regions [10]: a
median of 59X mean on-target depth is needed for the
same coverage in both of our more recent exome-seq data
sets. The equivalent figure was 18X for the TCGA-WGS
data set and 20X for the 1KG-WGS data set.
Sensitivity at sites in HumanGeneMutation Database
(HGMD)
Overall estimated sensitivity is a useful measure that can
be applied to more specific subsets of target regions.
For instance, estimating how many known disease caus-
ing or disease associated SNV sites can be recovered
given a particular sequencing strategy. To demonstrate
and at the same time discover if known disease causing
mutations are preferentially located in easy or difficult to
sequence regions of the genome: we obtained the loca-
tions of such coding and splice variants from HGMD [18].
From these we generated the coverage distributions for
disease-causing and disease-associated SNVs separately
to compare their overall estimated sensitivity with cod-
ing regions in general for both whole genome and exome
sequencing. For 87,663 disease-causing and 2,241 disease-
associated sites, we found no difference in the measure
across all four of our sample sets (Additional file 1:
Figure S10).
Characteristics of difficult target regions
As has previously been noted for both whole genome
and exome sequencing, regions of high G+C content
and regions containing repetitive elements are gener-
ally harder to sequence to high depth [19]. We define
difficult regions based on poor coverage (see Methods)
in at least half the samples from a given data set, and
easy regions based on excellent coverage (see Methods)
in all the samples from that set. Our samples show the
expected characteristics, with the bulk of difficult regions
occurring at G+C content above 60% (Additional file 1:
Figure S11), and with a significantly higher proportion
of difficult regions overlapping repetitive elements com-
pared to relatively easy target regions (Additional file 1:
Figure S12). The HGU-WXS data set also had a large
number of difficult target regions that were of low G+C
content. Because the classification of a region as difficult is
based on at least half the samples in a data set, this was not
caused by capture failure of one or a few samples; however,
a larger scale failure could be implicated. Very few target
regions were classed as difficult for the TCGA-WGS data
set for either of the two exome capture target region sets.
However, approximately one third of all regions identified
as difficult in any of the four data sets were classed that
way for both the TCGA-WXS and 1KG-WGS data set, and
15% for both the HGU-WXS and the 1KG-WGS data set
(Additional file 1: Figure S13).
To quantify the contributions of repetitive sequence
and nucleotide composition to target difficulty, we iden-
tified targets meeting our criteria for difficult (see
Methods) in any of the samples for a data set. The num-
ber of samples in which that target was defined as difficult
was multiply regressed against target G+C content, pres-
ence of annotated repeats and alignability [20]. All factors
were significant to p < 0.001; however, their predic-
tive power was slight (Additional file 1: Table S8). The
adjusted R-squareds were 0.265, 0.086, 0.150, and 0.171
for 1KG-WGS, HGU-WXS, TCGA-WGS, and TCGA-
WXS respectively. As the analysis was run on the intersec-
tion of the target capture regions for the two exome-seq
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Figure 4 Overall estimated sensitivity for targeted regions. Calculated from the per-site sensitivity for each data set combined with the depth
of coverage distributions for samples across the regions targeted by each of the two exome capture kits. a) HGU-WXS (Nimblegen SeqCap EZ
Exome v3). b) TCGA-WXS (Whole exome Agilent 1.1 plus boosters).
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data sets; the particularly low R-squared for the HGU-
WXS data set may be due to differences in probe design
but is not due to a different set of targets.
Cost of sequencing to a given level of sensitivity
We compared exome and whole genome sequencing costs
on current standard technology (Illumina HiSeq) with an
exome capture kit of the same size as the Nimblegen
SeqCap EZ Exome v3 (65Mbp) used for the HGU-WXS
samples, assuming 60% of exome reads on target (Table 1)
and holding the per sample cost of the exome capture
kit constant. To achieve 93–94% overall estimated het-
erozygous sensitivity in the coding regions of the genome,
exome sequencing is 4.2X cheaper than whole genome
sequencing (12 exome samples/lane vs. 1 lane/sample
whole genome). Likewise, for 98–99% sensitivity, exome
sequencing is 5.4X cheaper (4 exome samples/lane vs. 2
lanes/sample whole genome).
We estimate that the cost per lane of sequence would
have to be 15–20% of the current cost for the two meth-
ods to reach cost parity, holding the cost of exome capture
constant (Additional file 1: Figure S14). The projected
$1000 genome at 30X depth enabled by the Illumina
HiSeq X Ten (X10) system reaches this cost point for 93–
94% overall estimated heterozygous sensitivity in the cod-
ing regions of the genome. Holding the per sample exome
kit cost constant, the X10 system claims to sequence
genomes to 12X depth at 77% the cost of sequencing
exomes to 29X depth, with roughly equivalent sensitiv-
ity. However, for higher sensitivity of 98–99%, we estimate
thatWGS on the X10 system will still be 31%more expen-
sive than exome-seq, and decreases in exome capture kit
costs will likely keep the two methods at close to cost
parity.
Conclusions
Exome-seq target capture technology is clearly improv-
ing. Our previous results from a solution-based target
capture kit suggested a mean on-target depth of 46X
was needed to obtain 95% overall estimated sensitivity
for heterozygous SNPs [9]. The two data sets in this
analysis from more recent capture kits (HGU-WXS and
TCGA-WXS) show 40X is required for the same level of
sensitivity. This progressive improvement in technology
could partially explain the difference between our results
and the higher mean on-target depth of 80X suggested by
other previous analyses such as Clark et al. [10].
The mean on-target depth needed for 95% SNP detec-
tion sensitivity shown by our analysis of WGS data from
multiple sources is also lower than previous estimates
[12,13]. The earlier of these two estimates describes reads
from the first next-generation sequencing experiments,
which were shorter than the reads used for our WGS
samples, and additionally contained no paired-end reads.
The second estimate is more comparable in terms of
data, and we conclude that improvement in variant calling
algorithms is likely to be a factor in the difference here.
Uniformity of coverage is clearly still a major issue
for exome sequencing in terms of capturing a reason-
able number of reads across all of the targeted regions.
PCR amplification-free library preparation can mitigate
the issue somewhat for WGS samples [4,5] but it is still
required to provide a sufficiently large library for exome-
seq samples. Allele distribution biases introduced by the
reference bias of exome-seq target probes could be min-
imised by the use of alternate probes containing common
haplotypes, but the problem will remain for rare variants.
The additional allele distribution bias introduced by treat-
ing the reference genome as truth during computational
analysis affects bothWGS and again exome-seq and is not
easily fixed for rare variants.
The amount of raw sequencing is the main cost driver
for both WGS and exome-seq, and the drop in cost to the
$1000 human genome at 30X depth has brought the two
methods roughly into parity. However, smaller sequenc-
ing centres relying on the previous generation of machines
will continue to charge three to four times exome-seq
costs for the same level of SNP detection sensitivity across
coding regions using WGS. When taking into account the
considerably higher data storage requirements of WGS
Table 1 Cost of sequencing to achieve a given level of heterozygous SNV detection sensitivity
Method Lane usage Mean on-target depth Sensitivity Cost
Whole genome
1 lane/sample 11X 94.0% 4.60
2 lanes/sample 22X 98.5% 8.79
Exome
16 samples/lane 22X 91.1% 1.00
12 samples/lane 29X 93.4% 1.09
8 samples/lane 44X 95.9% 1.28
6 samples/lane 58X 96.9% 1.46
4 samples/lane 88X 98.1% 1.63
All costs have been normalised against the cheapest exome sequencing (16 samples per lane). Estimated costs include library preparation, exome capture and
multiplexing where applicable, and paired-end sequencing on Illumina HiSeq.
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and the extra compute time required to perform align-
ment and subsequent bioinformatic analyses on WGS
samples, the cost difference will be further amplified.
WGS provides a much richer data set, capturing
information on polymorphisms over whole genome and
potentially capturing genomic rearrangements. The dra-
matically improved uniformity of read coverage and
reduced bias of allele ratios inWGS, both lend themselves
to improved detection of copy number changes and mea-
surement of sample heterogeneity. These are likely to be
extremely useful measures in some settings, such as for
the sequencing of primary tumours whose analysis, even
when focused on the exome, is confounded by copy num-
ber change, sample heterogeneity and a desire to detect de
novomutations.
Methods
Exome capture and sequencing
The 13 HGU-WXS exomes were captured using a Nim-
blegen SeqCap EZ Exome v3 kit. Paired-end reads of 98
bp were generated on the Illumina HiSeq platform. Six
whole genome samples were downloaded from the 1000
Genomes Project [14] Pilot 2 (high coverage family trios).
Individuals with both whole genome and exome samples
from TCGA were filtered for cases with similar num-
bers of reads to the 1KG-WGS and HGU-WXS exome
samples. From these, 20 individuals with exome samples
labelled with the same set of target capture regions were
randomly selected. Exome alignments for all 20 individ-
uals and whole genome alignments for a random subset
of 10 individuals were downloaded from TCGA Data Por-
tal. Additional file 1: Table S1 summarises the technology
used to generate each of the four data sets.
Ethical approval and consent
The samples used for in-house exome sequencing were
collected under approval by the UK Multiregional Ethics
Committee (References: 06/MRE00/76 and 04/MRE00/
19).
Alignments
Reads for the 13 HGU-WXS exomes were aligned to
the hg19/GRCh37 assembly of the human genome ref-
erence sequence with BWA 0.5.9 [21]. Duplicate reads
were removed using the MarkDuplicates function of
Picard 1.79 (http://picard.sourceforge.net). Reads were re-
aligned around indels and quality scores re-calibrated
using the Genome Analysis Toolkit (GATK) 2.2-8-
gec077cd [22]. Full parameters are given in the Additional
file 1: Supplementary Information and Additional file 4.
We randomly down-sampled reads from exome align-
ments using Picard DownsampleSam, which maintains
read pair information. The probability of sampling each
read varied from 0.1 to 0.9 at intervals of 0.1.
Target regions
We defined a common set of target regions using the cod-
ing regions of exons from Ensembl 72 [17]. The coding
regions were merged so that every position was repre-
sented only once, 50bp of flanking sequence added to each
resulting region, and the regions merged again. We also
used the provided targets for the Nimblegen SeqCap EZ
Exome v3 kit, a set of targets labelled ‘Whole exome Agi-
lent 1.1 RefSeq plus 3 boosters’ obtained directly from
TCGA, and a merged set of these two targets.
Mapped read depth across all the target regions was
calculated using the DepthOfCoverage tool from GATK
2.6-5-gba531bd [22]. The target regions were split into
maximally 100bp non-overlapping tiles for further anal-
ysis, with small tiles at target region edges. We defined
difficult target region tiles as those with fewer than 50%
of their bases covered at least 15X in the full align-
ments for at least half of the samples in a given data
set, and easy target region tiles as those with all their
bases covered at least 15X in the full alignments for all
the samples in a given data set. G+C content for tar-
get regions was obtained using the GCContentByInterval
tool fromGATKGenomeAnalysisTK-2.5-2-gf57256b, and
repeat element occurrences were mapped from Ensembl
73. HGMD disease causing mutations were obtained from
the HGMD Professional database (March 2013 release).
Multiple linear regression of number of samples where
a target region had less than 50% of bases covered at
least 15X in the full alignment was performed using R
lm on factors G+C content, presence of repeats, and
alignability [20] with no interactions, where at least one
sample met the criteria for a given data set. Alignabil-
ity tracks were downloaded from the UCSC Genome
Browser [23]. 36mer alignability was used for 1KG-WGS
samples, 75mer for TCGA-WXS, and 100mer for HGU-
WXS and TCGA-WGS, to best match the read lengths for
each data set (Additional file 1: Table S1).
Variants
Variants were called on the full and down-sampled align-
ments using the GATK 2.6-5-gba531bd UnifiedGeno-
typer tool [24], one sample at a time (full parameters
in Additional file 1: Supplementary Information). We
obtained HapMap Phase III sites and genotypes from the
project FTP site [16]. Variants from this set were mapped
by position and alleles to called variants in the full and
down-sampled alignments. Additional variant calls were
made by grouping samples by data source and running the
UnifiedGenotyper tool on the full alignments for samples
within each group.
Sensitivity
Sensitivity for per-site mapped read depth and estimated
overall sensitivity were calculated as in [9], using sites
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http://www.biomedcentral.com/1471-2105/15/247
in HapMap 3.3 and the Ensembl 72 coding regions with
minimum genotype quality of 60 in the full alignments.
Availability of supporting data
The TCGA-WXS and TCGA-WGS data are available
through dbGaP and the Cancer Genome Hub (http://
cghub.ucsc.edu/) and 1KG-WGS data from the 1000
Genomes Project (http://www.1000genomes.org/data),
see Additional file 1: Table S2 for accession identifiers.
Reads for the HGU-WXS exome sequence data are avail-
able upon request. VCF files containing the HapMap 3.3
SNP sites and associated genotype calls and read depths
in the downsampled and full alignments used to generate
the main results in this article are included as additional
files. The command lines for producing the downsampled
alignments and calling variants are included as a plain text
additional file.
Additional files
Additional file 1: Supplementary Information. Supplementary
methods, figures, and small tables.
Additional file 2: Supplementary Tables. Large supplementary tables.
Additional file 3: VCF files of HapMap 3.3 coding sites and genotypes.
Additional file 4: Command lines.
Abbreviations
1KG: 1000 Genomes Project; HGU: Human Genetics Unit; GATK: Genome
Analysis ToolKit; TCGA: The Cancer Genome Atlas; TCGA-WXS: TCGA Whole
eXome Sequence; TCGA-WGS: TCGA Whole genome sequence.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AMM and MST designed the analysis and wrote the manuscript. AMM
performed the analysis. MA and DRF provided and sequenced the HGU-WXS
exomes. All authors read and approved the final manuscript.
Acknowledgements
We thank Edinburgh Genomics for providing information regarding the
relative costs of whole genome sequencing and targeted exome capture
followed by sequencing. This work was supported by the UK Medical Research
Council and the Medical Research Foundation.
Received: 7 February 2014 Accepted: 7 July 2014
Published: 19 July 2014
References
1. Wetterstrand KA: DNA Sequencing Costs: Data from the NHGRI
Genome Sequencing Program. 2013. [http://www.genome.gov/
sequencingcosts/]
2. Cooper DN, Krawczak M, Antonarakis S. In TheMetabolic andMolecular
Bases of Inherited Disease. 7th edn. Edited by Scriver C, Beaudet A, Sly W,
Valle D, Childs B, Kinzler K, Vogelstein B. New York: McGraw Hill;
1995:259–291.
3. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A,
Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS,
Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL,
Gibbs RA, Eng CM: Clinical whole-exome sequencing for the diagnosis
of mendelian disorders. N Engl J Med 2013, 369(16):1502–1511.
4. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ:
Amplification-free Illumina sequencing-library preparation
facilitates improvedmapping and assembly of (G+C)-biased
genomes. Nat Methods 2009, 6(4):291–295.
5. Aird D, Ross MG, Chen W-S, Danielsson M, Fennell T, Russ C, Jaffe DB,
Nusbaum C, Gnirke A: Analyzing andminimizing PCR amplification
bias in Illumina sequencing libraries. Genome Biol 2011, 12(2):18.
6. Veal CD, Freeman PJ, Jacobs K, Lancaster O, Jamain S, Leboyer M, Albanes
D, Vaghela RR, Gut I, Chanock SJ, Brookes AJ: Amechanistic basis for
amplification differences between samples and between genome
regions. BMC Genomics 2012, 13:455.
7. Quail MA, Kozarewa I, Smith F, Scally A, Stephens PJ, Durbin R, Swerdlow
H, Turner DJ: A large genome center’s improvements to the Illumina
sequencing system. Nat Methods 2008, 5(12):1005–1010.
8. Heinrich V, Stange J, Dickhaus T, Imkeller P, Krüger U, Bauer S, Mundlos S,
Robinson PN, Hecht J, Krawitz PM: The allele distribution in
next-generation sequencing data sets is accurately described as the
result of a stochastic branching process. Nucleic Acids Res 2012,
40(6):2426–2431.
9. Meynert AM, Bicknell LS, Hurles ME, Jackson AP, Taylor MS: Quantifying
single nucleotide variant detection sensitivity in exome
sequencing. BMC Bioinformatics 2013, 14:195.
10. Clark MJ, Chen R, Lam HYK, Karczewski KJ, Chen R, Euskirchen G, Butte AJ,
Snyder M: Performance comparison of exome DNA sequencing
technologies. Nature Biotechnologyotech 2011, 29(10):908–914.
11. Sulonen A-M, Ellonen P, Almusa H, Lepisto M, Eldfors S, Hannula S,
Miettinen T, Tyynismaa H, Salo P, Heckman C, Joensuu H, Raivio T,
Suomalainen A, Saarela J: Comparison of solution-based exome
capture methods for next generation sequencing. Genome Biol 2011,
12(9):94.
12. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown
CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ,
Keira Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray
SJ, Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ,
Obradovic B, Ost T, Parkinson ML, Pratt MR, et al: Accurate whole human
genome sequencing using reversible terminator chemistry. Nature
2008, 456(7218):53–59.
13. Ajay SS, Parker SC, Ozel Abaan H, Fuentes Fajardo KV, Margulies EH:
Accurate and comprehensive sequencing of personal genomes.
Genome Res 2011, 21(9):1498–1505.
14. 1000 Genomes Project Consortium, Durbin RM, Abecasis GR, Altshuler DL,
Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA: Amap
of human genome variation from population-scale sequencing.
Nature 2010, 467(7319):1061–1073.
15. Zook JM, Chapman B, Wang J, Mittelman D, Hofmann O, Hide W, Salit M:
Integrating human sequence data sets provides a resource of
benchmark SNP and indel genotype calls. Nat Biotechnol 2014,
32(3):246–251.
16. The International HapMap 3 Consortium: Integrating common and rare
genetic variation in diverse human populations. Nature 2010,
467(7311):52–58.
17. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D,
Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, García-Girón C, Gordon
L, Hourlier T, Hunt S, Juettemann T, Kähäri AK, Keenan S, Komorowska M,
Kulesha E, Longden I, Maurel T, McLaren WM, Muffato M, Nag R, Overduin
B, Pignatelli M, Pritchard B, Pritchard E, et al: Ensembl 2013. Nucleic Acids
Res 2013, 41(Database issue):48–55.
18. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NST,
Abeysinghe S, Krawczak M, Cooper DN: Human Gene Mutation
Database (HGMD): 2003 update. HumMutat 2003, 21(6):577–581.
19. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP: Sequencing depth and
coverage: key considerations in genomic analyses. Nat Rev Genet
2014, 15(2):121–132.
20. Derrien T, Estellé J, Marco Sola S, Knowles DG, Raineri E, Guigó R, Ribeca P:
Fast computation and applications of genomemappability. PloS One
2012, 7(1):30377.
21. Li H, Durbin R: Fast and accurate short read alignment with
Burrows-Wheeler transform. Bioinformatics 2009, 25(14):1754–1760.
22. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A,
Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The Genome
Analysis Toolkit: a MapReduce framework for analyzing
next-generation DNA sequencing data. Genome Res 2010,
20(9):1297–1303.
Meynert et al. BMC Bioinformatics 2014, 15:247 Page 11 of 11
http://www.biomedcentral.com/1471-2105/15/247
23. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler
D: The human genome browser at UCSC. Genome Res 2002,
12(6):996–1006.
24. Depristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C,
Philippakis AA, Del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ,
Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ:
A framework for variation discovery and genotyping using
next-generation DNA sequencing data. Nat Genet 2011, 43(5):491–498.
doi:10.1186/1471-2105-15-247
Cite this article as:Meynert et al.: Variant detection sensitivity and biases
in whole genome and exome sequencing. BMC Bioinformatics 2014 15:247.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
